What are the Challenges in Developing Catalytic Anticancer Therapies?
Despite the promising potential, there are several challenges in developing catalytic anticancer therapies:
Toxicity: Some catalysts, especially metal-based ones, can be toxic to healthy cells. Designing catalysts with high selectivity and low toxicity is crucial. li> Stability: Catalysts need to be stable under physiological conditions to be effective in vivo. Ensuring the stability of catalysts is a key aspect of their design. Delivery: Efficient delivery systems are required to transport catalysts to the target site within the body. Nanocarriers and other delivery mechanisms are actively being researched.
